S. Tremblay, V. Nigro, J. Weinberg, E. Woodle, and R. Alloway, A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study, American Journal of Transplantation, vol.42, issue.Suppl 2, pp.432-442, 2017.
DOI : 10.1016/j.transproceed.2010.09.052

A. Gaber, R. Alloway, K. Bodziak, B. Kaplan, and S. Bunnapradist, Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT), Transplantation Journal, vol.96, issue.2, pp.191-197, 2013.
DOI : 10.1097/TP.0b013e3182962cc1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723088

L. Borra, J. Roodnat, J. Kal, R. Mathot, W. Weimar et al., High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation, Nephrology Dialysis Transplantation, vol.25, issue.8, pp.2757-2763, 2010.
DOI : 10.1093/ndt/gfq096

E. Rodrigo, D. Segundo, and G. Fernandez-fresnedo, Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development, Transplantation, vol.100, issue.11, pp.2479-2485, 2016.
DOI : 10.1097/TP.0000000000001040

T. Vanhove, T. Vermeulen, P. Annaert, E. Lerut, and D. Kuypers, High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients, American Journal of Transplantation, vol.90, issue.10, 2016.
DOI : 10.1097/TP.0b013e3181e065de